Clinical Trial Update: Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

View source ↗

Summary

Completed RadComp companion study evaluating cardiotoxicity risk in breast cancer patients receiving proton versus photon radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer, Cardiotoxicity | Status: COMPLETED